Alex Reyentovich, M.D.
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in New York, New York, trained at Geisel School of Medicine at Dartmouth (class of 2002). In 2024 Medicare paid $120,854 for 358 patients, and Part D covered 615 of their prescriptions, 73% of them generic. Alnylam Pharmaceuticals Inc. was the largest of 13 companies reporting payments in 2025, $14,674 in all, mostly consulting fees.
Overview
| NPI | 1588723662 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Dec 6, 2006 |
| Last updated in NPPES | Mar 23, 2021 |
| Certified by provider | Mar 23, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 232432 | NY |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 232432 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 358 |
|---|---|
| Services billed | 1,214 across 24 procedure codes |
| Paid by Medicare | $120,854 |
Part D prescriptions in 2024
| Prescriptions (claims) | 615 · 1,378 30-day fills |
|---|---|
| Patients | 144 |
| Total drug cost | $176,209 |
| Generic share | 73% of claims |
Education and affiliations
| Medical school | Geisel School of Medicine at Dartmouth |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- New York UniversityNew York, NY · 6,134 clinicians
Hospital affiliation
- NYU Langone HospitalsNew York, NY
Other facilities
- Rusk RehabilitationInpatient rehabilitation facility · New York, NY
Industry payments (Open Payments)
- 2025$14,674 · 52 payments from 13 companies
- 2024$5,235 · 30 payments from 13 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $7,418 | 10 |
| Pfizer Inc. | $6,099 | 8 |
| Abbott Laboratories | $370.90 | 4 |
| Bridgebio Pharma, Inc. | $234.78 | 5 |
| Merck Sharp & Dohme LLC | $137.06 | 6 |
What the 2025 payments were for
- Consulting Fee$12,938 · 4 payments
- Food and Beverage$1,673 · 47 payments
- Travel and Lodging$62.80 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York
- 1023351541
- 1043417157
- 1043699614
- 1053706325
- 1063775419
- 1073994208
- 1134354723
- 1174524474
- 1184864621
- 1194879825
- 1225115082
- 1235312331
All 60 Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York · All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York